We observed that only three studies captured information on interleukin-6 (IL-6) levels among patients with COVID-19 and stroke, which ranged from 3 to 10.5 pg/mL, which are the studies by Avula et al. (42), Barios Lopez et al. (44), and Yaghi et al. (36). This evidence concerns the gene IL6 and COVID-19.